Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical heterogeneity of acquired hemophilia A: a description of 4 cases.

Haematologica - 1 Mar 2005

Franchini Massimo, Girelli Domenico, Olivieri Oliviero, Bozzini Claudia, Guiotto Maria, Zardini Gabriele, Lippi Giuseppe, Manzato Franco, Gandin Giorgio

Abstract excerpt

Acquired hemophilia A is a rare but severe auto-immune bleeding disorder characterized by the presence of autoantibodies directed against clotting factor VIII. Acquired hemophilia A may be idiopathic or associated with several conditions, such as postpartum, autoimmune diseases, malignancies or drugs. The treatment modalities of bleeding episodes and eradication of the factor VIII auto-antibody depend on the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Factor VIII

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to VWF gene

Share to Hemophilia A

Share to Phenotype

Share to Prognosis

Source

Identifiers

PMID: 15753057

Genes

VWF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical heterogeneity of acquired hemophilia A: a description of 4 cases.PMID 15753057Read ↗

Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan.Semantic proximity Read ↗

Acquired hemophilia A: Updated review of evidence and treatment guidance.Semantic proximity Read ↗

Genetics and Epigenetics in Acquired Hemophilia A: From Bench to BedsideSemantic proximity Read ↗

Autoimmune acquired factor XIII deficiency due to anti-factor XIII/13 antibodies: A summary of 93 patients.Semantic proximity Read ↗

[Acquired von Willebrand syndrome: from diagnosis to treatment].Semantic proximity Read ↗

Development of inhibitors in hemophilia A: An illustrated reviewSemantic proximity Read ↗

Predictive significance of anti-FVIII immunoglobulin patterns on bleeding phenotype and outcomes in acquired hemophilia A: Results from the Quebec Reference Center for Inhibitors.Semantic proximity Read ↗

Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism.Semantic proximity Read ↗

Anti-CD19 CAR-T cell therapy for acquired hemophilia ASemantic proximity Read ↗

Factor VIII inhibitors.Semantic proximity Read ↗

Current debates in antiphospholipid syndrome: the acquired antibody-mediated thrombophilia.Semantic proximity Read ↗

[Perioperative therapy of von Willebrand disease. Demonstration of pathophysiology, clinical problems and therapy options using two case reports].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.